Advertisement

HindustanTimes Fri,18 Apr 2014

Infosys shares down nearly 3% in early trade on profit-booking

PTI  Mumbai, July 15, 2013
First Published: 11:14 IST(15/7/2013) | Last Updated: 13:49 IST(15/7/2013)

Shares of IT major Infosys on Monday fell by nearly 3% in early trade on profit-booking, after the stock had a smart rally in the previous session on better-than-expected first quarter earnings.

Advertisement

After making a weak opening, the stock further lost 2.62% to Rs. 2,729.05 on the BSE.

At the NSE, the scrip was down 2.7% to Rs. 2,728.30.

Dip in the stock was significant in sending the BSE benchmark Sensex down by 34.37 points to 19,924.10 at 1145 hrs. Infosys alone contributed 27.24 points to the overall Sensex fall.

Shares of IT major Infosys had on Friday ended with nearly 11% gains, after the company posted a near 4% increase in consolidated net profit for the April-June quarter, meeting market expectations.

The company's consolidated net profit rose by 3.7% to Rs. 2,374 crore for the April-June quarter against Rs. 2,289 crore in the year-ago period. Its consolidated revenues rose 17.2% to Rs. 11,267 crore from Rs. 9,616 crore in the year-ago period.

Shares of IT major Infosys today fellby nearly 3% in early trade on profit-booking, after the stock had a smart rally in the previous session on better-than-expected first quarter earnings.

After making a weak opening, the stock further lost 2.62% to Rs. 2,729.05 on the BSE.

At the NSE, the scrip was down 2.7% to Rs. 2,728.30.

Dip in the stock was significant in sending the BSE benchmark Sensex down by 34.37 points to 19,924.10 at 1145 hrs. Infosys alone contributed 27.24 points to the overall Sensex fall.

Shares of IT major Infosys had on Friday ended with nearly 11% gains, after the company posted a near 4% increase in consolidated net profit for the April-June quarter, meeting market expectations.

The company's consolidated net profit rose by 3.7% to Rs. 2,374 crore for the April-June quarter against Rs. 2,289 crore in the year-ago period. Its consolidated revenues rose 17.2% to Rs. 11,267 crore from Rs. 9,616 crore in the year-ago period.

Advertisement
more from Business

Glenmark pulls 2,900 bottles of ulcer drug in US

India's Glenmark Pharmaceuticals Ltd is recalling some  2,900 bottles of its stomach ulcer drug ranitidine in the United States after a foreign tablet was found in one of the bottles.

markets
Advertisement
Most Popular
Advertisement
Copyright © 2014 HT Media Limited. All Rights Reserved